Screener
Medpace Holdings, Inc. MEDP Business Segments — Total Revenue
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Medpace Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Medpace Holdings, Inc.’s 10-Q, filed July 23, 2026.
- Filed
- Jul 23, 2026, 4:03 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001668397-26-000025
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Revenue, net | $707,331 | $603,311 | $1,413,935 | $1,161,881 |
| Operating expenses: | ||||
| Direct service costs, excluding depreciation and amortization - Employee compensation | 163,089 | 147,942 | 327,692 | 291,869 |
| Direct service costs, excluding depreciation and amortization - Other segment items (a) | 39,466 | 37,884 | 73,137 | 71,773 |
| Reimbursed out-of-pocket expenses | 303,139 | 237,472 | 615,143 | 439,876 |
| Total direct costs | 505,694 | 423,298 | 1,015,972 | 803,518 |
| Selling, general and administrative | 48,103 | 46,664 | 96,020 | 104,561 |
| Depreciation | 6,555 | 6,777 | 13,306 | 13,471 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Medpace Holdings, Inc.'s business segments — total revenue?
- Medpace Holdings, Inc. (MEDP) reported business segments — total revenue of $707.33M in Q2 2026.
- How has Medpace Holdings, Inc.'s business segments — total revenue changed year-over-year?
- Medpace Holdings, Inc.'s business segments — total revenue increased by 17.2% year-over-year, from $603.31M to $707.33M.
- What is the long-term trend for Medpace Holdings, Inc.'s business segments — total revenue?
- Over 3 years (2022 to 2025), Medpace Holdings, Inc.'s business segments — total revenue has grown at a 20.1% compound annual growth rate (CAGR), from $1.46B to $2.53B.
- What does business segments — total revenue mean?
- Represents the total gross inflow of economic benefits arising from the ordinary operating activities of the reportable business segment. This includes fees earned from providing clinical trial services, bioanalytical laboratory work, and imaging capabilities to biotechnology and pharmaceutical clients.
Ask your AI about Medpace Holdings, Inc.'s business segments — total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude